- Home
- RELL vs CRVO Comparison
RELL vs CRVO Comparison
Compare RELL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELL | CRVO |
|---|---|---|
| Founded | 1947 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.6M | 78.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RELL | CRVO |
|---|---|---|
| Price | $10.85 | $7.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | ★ 54.8K | 53.4K |
| Earning Date | 01-07-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $209,791,000.00 | $6,159,786.00 |
| Revenue This Year | $4.72 | N/A |
| Revenue Next Year | $14.93 | N/A |
| P/E Ratio | $901.70 | ★ N/A |
| Revenue Growth | ★ 6.17 | N/A |
| 52 Week Low | $7.57 | $1.92 |
| 52 Week High | $15.38 | $16.94 |
Technical Indicators
Market Signals| Indicator | RELL | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 53.89 | 44.62 |
| Support Level | $10.42 | $7.60 |
| Resistance Level | $11.16 | $8.46 |
| Average True Range (ATR) | 0.36 | 0.52 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 44.89 | 39.93 |
Price Performance
Historical ComparisonAbout RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.